Every day thousands of people in the USA are beginning to fight cancer. In 2016, more than 4,600 individuals in the U.S. were diagnosed with cancer daily. The first step to fighting cancer is identifying its presence early, which can be a difficult and frustrating process.
The IvyGene test is a blood test that uses advanced DNA sequencing methods to detect the DNA methylation pattern of circulating tumor DNA (ctDNA) in blood samples in order to both confirm the presence of cancer and give measurable information about cancer. The IvyGene test is a non-invasive, accurate tool to aid physicians in confirming cancer presence at the time of testing.
According to studies performed by the National Cancer Institute and the American Cancer Society, individuals who identified 25 different types of cancer earlier had a greater chance of survival. In combination with diagnostic tests, the IvyGene test is another step towards winning the battle with cancer.
The IvyGene® Test measures the methylation status of cell-free DNA extracted from blood samples at target gene sites. These target sites have been demonstrated to be hypermethylated when certain cancers are present. Test results are reported as a quantitative IvyGene® Score, which indicates the methylation status of the target sites. The IvyGene® Score is calculated as a composite average of cell-free DNA that is methylated at the target sites as a fraction of the total cell-free DNA present.
Many DNA tests identify the "propensity to have" or the "likelihood" that cancer will occur. The IvyGene test identifies actual disease presence at the time of testing.
Click here to review a SAMPLE REPORT.
Click here to download a FULL BROCHURE.
CLICK HERE to go to the Test Menu and Order the Test.(You must be logged into your Evexia account)